Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy and PPD for Multiple Common Warts
NCT04288817Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Mar 2020
- Primary completion
- Mar 2021
01
Overview
Phase 3, randomised, open-label trial of tuberculin purified protein derivative in common wart, sponsored by Assiut University. Primary endpoints: Size of lesions at 2 months and Number of lesions at 4 months. Status: unknown.
02
Drugs
tuberculin purified protein derivative
03
Conditions
common wart
Beyond the preview
Go deeper on NCT04288817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04288817.